News Takeda builds in cancer with monster $11.4bn Innovent deal Takeda has partnered with China's Innovent for a pair of late-stage cancer therapies, in a deal that includes an upfront payment of $1.2bn.
News Novartis agrees $5.7bn degrader deal with Monte Rosa Novartis has signed its second multibillion-dollar licensing deal with molecular glue degrader specialist Monte Rosa in less than a year.
News Lilly offers AI discovery models to biotech partners Eli Lilly is offering AI-powered drug discovery models developed at a cost of around $1 billion to biotech companies for free.
Market Access Why impactful and scalable global Medical Information (MI) p... A trusted MI partner ensures compliance with global and local regulations and provides consistent access to accurate medical information.
Sales & Marketing 5 Things to watch at Fierce Pharma Week 2025: What every pha... Fierce Pharma Week 2025, 8th to 11th September 2025 in Philadelphia marks a historic shift in pharmaceutical industry events.
News OMass attracts $420m Roche wager on IBD programme UK biotech OMass has revealed its first major pharma partnership, with Roche paying $20m upfront for an inflammatory bowel disease programme.
Patients LSX2026: On promise and patience, with Hans Schambye At LSX World Congress 2026 in Lisbon, Portugal, web editor Nicole Raleigh spoke with Hans Schambye, CEO of BOOST Pharma.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.